PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 253 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,067 | -24.1% | 34,783 | -0.9% | 0.00% | 0.0% |
| Q2 2023 | $1,406 | -3.2% | 35,083 | -1.4% | 0.00% | 0.0% |
| Q1 2023 | $1,452 | +4.9% | 35,583 | -0.7% | 0.00% | 0.0% |
| Q4 2022 | $1,384 | -99.9% | 35,836 | +0.3% | 0.00% | -40.0% |
| Q3 2022 | $1,901,000 | -8.5% | 35,736 | +0.3% | 0.01% | 0.0% |
| Q2 2022 | $2,078,000 | -23.4% | 35,636 | +0.3% | 0.01% | -16.7% |
| Q1 2022 | $2,712,000 | +26.8% | 35,536 | 0.0% | 0.01% | +50.0% |
| Q4 2021 | $2,138,000 | +7.4% | 35,536 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,990,000 | -8.2% | 35,536 | -0.5% | 0.00% | -20.0% |
| Q2 2021 | $2,167,000 | -13.4% | 35,709 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $2,503,000 | +19.5% | 35,709 | +2.0% | 0.01% | 0.0% |
| Q4 2020 | $2,095,000 | -0.5% | 35,011 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $2,105,000 | +11.4% | 35,011 | -2.8% | 0.01% | 0.0% |
| Q2 2020 | $1,890,000 | +57.0% | 36,012 | +0.3% | 0.01% | +25.0% |
| Q1 2020 | $1,204,000 | -17.8% | 35,912 | +11.1% | 0.00% | +33.3% |
| Q4 2019 | $1,464,000 | +133.5% | 32,312 | +96.1% | 0.00% | +50.0% |
| Q3 2019 | $627,000 | – | 16,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |